Gsk3β, which is associated with neurodegenerative diseases, including Alzheimer’s disease, is predominantly expressed in the central nervous system and has been reported to phosphorylate SREBP-1c and promote its degradation upon activation (Dong et al, 2015). This evidence concerns the gene GSK3B and neurodegenerative disease.